Arkolith/Insider Trading/FDMT/Form 4

Gupta Ashoo

VP, Finance and Controller4D Molecular Therapeutics, Inc. (FDMT) · full profile →Form 4 · filed Mar 24, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3K
Net Open-Market Flow
-$3K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 20, 2026Sell(S)310$8.61$3K47K
Mar 20, 2026Option exercise(M)865——47K
Mar 20, 2026Option exercise(M)221——47K
Mar 20, 2026Sell(S)80$8.61$68947K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 20, 2026Option exercise(M)865—$012K
Mar 20, 2026Option exercise(M)221—$03K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-122341) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML